MELANOMA STAGE IIIB-IV

Clinical trials for MELANOMA STAGE IIIB-IV explained in plain language.

Never miss a new study

Get alerted when new MELANOMA STAGE IIIB-IV trials appear

Sign up with your email to follow new studies for MELANOMA STAGE IIIB-IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat skin cancer

Disease control Recruiting now

This study is testing a new oral drug, LNS8801, for people with advanced melanoma that has spread and no longer responds to standard immunotherapies. Researchers want to see if LNS8801, taken alone or combined with the drug pembrolizumab, can stop or slow cancer growth better tha…

Matched conditions: MELANOMA STAGE IIIB-IV

Phase: PHASE2, PHASE3 • Sponsor: Linnaeus Therapeutics, Inc. • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

MELANOMA STAGE IIIB-IV

Get alerted when new MELANOMA STAGE IIIB-IV trials appear

New hope for Tough-to-Treat skin cancer